Chemistry: molecular biology and microbiology – Measuring or testing process involving enzymes or... – Involving nucleic acid
Reexamination Certificate
2007-08-30
2010-12-28
Myers, Carla (Department: 1634)
Chemistry: molecular biology and microbiology
Measuring or testing process involving enzymes or...
Involving nucleic acid
C536S023100, C536S023500, C536S024100
Reexamination Certificate
active
07858313
ABSTRACT:
A method of evaluating drug sensitivity or disease vulnerability, includes linking a gene polymorphism in a GIRK channel gene or a haplotype comprising the gene polymorphism to individual drug sensitivity or individual disease vulnerability.
REFERENCES:
patent: 2004/0214324 (2004-10-01), Isacson et al.
patent: 2005/0287574 (2005-12-01), Soykan et al.
patent: 2007/0258898 (2007-11-01), Ballinger et al.
patent: 2008/0248470 (2008-10-01), Kim et al.
Halushka et all. Nature. Jul. 1999. 22: 239-247.
Hirschhorn et al. Genetics in Medicine. 2002. 4(2): 45-61.
Suzuki et al. Eur Arch Psychiatry Clin Neurosci (2001). 251: 57-59.
NCBI SNP Database, National Center for Biotechnology Information, National Library of Medicine, NIH (Bethesda, MD, USA) rs2070995, GenBank Accession S78684, Jul. 9, 2001.
Tanizawa et al., “A human pancreatic islet inwardly rectifying potassium channel: cDNA cloning, determination of the genomic structure and genetic variations in Japanese NIDDM patients,” Diabetologia (1996) vol. 39, pp. 447-452.
Penn et al., “Single exon nucleic acid probes for analyzing gene expression in human hearts,” XP-002463412, Database accession No. ABA25297, Jan. 23, 2002.
“NEDO human cDNA sequencing project,” XP-002463413, Database accession No. DB310545, Feb. 27, 2006.
Blednov et al., “A pervasive mechanism for analgesia: Activation of GIRK2 channels,” Proceedings of the National Academy of Sciences of USA, Jan. 7, 2003, vol. 100, No. 1, pp. 277-282, XP-002328189.
Marker et al., “Hyperalgesia and blunted morphine analgesia in G protein-gated potassium channel subunit knockout mice,” Neuroreport, vol. 13, No. 18, p. 2509-2513, Dec. 20, 2002, XP-002971124.
Marker et al., “Spinal G-Protein-Gated K+ Channels Formed by GIRK1 and GIRK2 Subunits Modulate Thermal Nociception and Contribute to Morphine Analgesia,” The Journal of Neuroscience, Mar. 17, 2004, vol. 24, No. 11, pp. 2806-2812, XP-002463411.
Ocana et al., “Potassium channels and pain: present realities and future opportunities,” European Journal of Pharmacology, vol. 500, (2004), pp. 203-219.
Sakura et al., “Characterization and variation of a human inwardly-rectifying K-channel gene (KCNJ6): a putative ATP-sensitive K-channel subunit,” FEBS Letters, vol. 367 (1995) pp. 193-197, XP-002298421.
Hallmann et al., “Mutation Analysis of the Inwardly Rectifying K+ Channels KCNJ6 (GIRK2) and KCNJ3 (GIRK1) in Juvenile Myoclonic Epilepsy,” American Journal of Medical Genetics (Neuropsychiatric Genetics) vol. 96, pp. 8-11, (2000) XP-002298426.
Vaughn et al., “Genomic Structure and Expression of Human KCNJ9 (Kir3.3/GIRK3),” Biochemical and Biophysical Research Communications, vol. 274, pp. 302-309, (2000) XP-002324142.
Kazutaka Ikeda et al., “Involvement of G-Protein-Activated Inwardly Rectifying K+(GIRK) Channels in Opioid-Induced Analgesia,” Neuroscience Research vol. 38, pp. 113-116 (2000).
Toru Kobayashi et al., “Ethanol Opens G-Protein-Activated Inwardly Rectifying K+Channels,” nature neuroscience, vol. 2, No. 12, pp. 1091-1097 (Dec. 1999).
Kazutaka Ikeda et al., “Molecular Mechanisms of Analgesia Induced by Opioids and Ethanol: Is the GIRK Channel One of the Keys?,” Neuroscience Research, vol. 44, 121-131 (2002).
Toru Kobayashi et al., “G Protein-Activated Inwardly Rectifying Potassium Channels as Potential Therapeutic Targets,” Current Pharmaceutical Design, vol. 12, 4513-4523 (2006).
Kazutaka Ikeda et al., “How Individual Sensitivity to Opiates Can Be Predicted by Gene Analyses,” TRENDS in Pharmacological Sciences, vol. 26, No. 6, pp. 311-317 (Jun. 2005).
Hayashida Masakazu
Ikeda Kazutaka
Nishizawa Daisuke
Sora Ichiro
Birch & Stewart Kolasch & Birch, LLP
Myers Carla
Tokyo Metropolitan Organization for Medical Research
LandOfFree
Method of evaluating drug sensitivity by analyzing GIRK... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of evaluating drug sensitivity by analyzing GIRK..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of evaluating drug sensitivity by analyzing GIRK... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4180180